Evaluation and clinical management of interstitial lung abnormalities: Position paper of the Austrian Society of Pneumology (ÖGP) and the Austrian Radiological Society (ÖRG) 2026间质性肺异常的评价与临床管理:奥地利肺科学会(ÖGP)和奥地利放射学会(ÖRG)2026年立场文件Wiener Klinische WochenschriftIF2.12026-02-010OAAI
Functional Improvement at One Year in Fibrotic Interstitial Lung Diseases-Prognostic Value of Baseline Biomarkers and Anti-Inflammatory TherapiesDIAGNOSTICSIF3.32024-07-171OAAI
Functional improvement at one year in fibrotic interstitial lung diseases (ILD) - impact of baseline biomarkers and anti-inflammatory therapiesEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Clinical, imaging, and blood biomarkers to assess 1-year progression risk in fibrotic interstitial lung diseases-Development and validation of the honeycombing, traction bronchiectasis, and monocyte (HTM)-scoreFRONTIERS IN MEDICINEIF32022-11-166OAAI